PROFOUND MEDICAL CORP. Net Fee Amt
PROFOUND MEDICAL CORP. (PROF) had Net Fee Amt of $914.29 as of 2026-05-08, per its S-3 filed 2026-05-12.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-05-12
- 2026-05-08: Net Fee Amt $914.29.
| Period end | Net Fee Amt |
|---|---|
| 2026-05-08 | $914.29 S-3 · filed 2026-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |